ATE260933T1 - Peptide und gewinnungsverfahren - Google Patents

Peptide und gewinnungsverfahren

Info

Publication number: ATE260933T1
Authority: AT; Austria
Prior art keywords: trp; nval; ile; tyr; phe
Prior art date: 1995-06-07

Application number

AT96915261T

Other languages

English (en)

Inventor

Vladislav Isakovich Deigin

Andrei Marxovich Korotkov

Original Assignee

Immunotech Dev Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-07

Filing date

1996-05-06

Publication date

2004-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20168146&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE260933(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-05-06 Application filed by Immunotech Dev Inc filed Critical Immunotech Dev Inc

2004-03-15 Application granted granted Critical

2004-03-15 Publication of ATE260933T1 publication Critical patent/ATE260933T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
238000000034 method Methods 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 4
OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 abstract 2
SLXKOJJOQWFEFD-UHFFFAOYSA-M 6-aminohexanoate Chemical compound NCCCCCC([O-])=O SLXKOJJOQWFEFD-UHFFFAOYSA-M 0.000 abstract 2
AGPKZVBTJJNPAG-RFZPGFLSSA-N D-Isoleucine Chemical compound CC[C@@H](C)[C@@H](N)C(O)=O AGPKZVBTJJNPAG-RFZPGFLSSA-N 0.000 abstract 2
ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 abstract 2
QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 2
ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 abstract 2
COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 abstract 2
QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 abstract 2
OUYCCCASQSFEME-MRVPVSSYSA-N D-tyrosine Chemical compound OC(=O)[C@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 abstract 2
KZSNJWFQEVHDMF-SCSAIBSYSA-N D-valine Chemical compound CC(C)[C@@H](N)C(O)=O KZSNJWFQEVHDMF-SCSAIBSYSA-N 0.000 abstract 2
SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 abstract 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 2
125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 abstract 2
125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 abstract 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
230000015572 biosynthetic process Effects 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
229960003692 gamma aminobutyric acid Drugs 0.000 abstract 2
230000004957 immunoregulator effect Effects 0.000 abstract 2
238000003786 synthesis reaction Methods 0.000 abstract 2
WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
150000001408 amides Chemical class 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
150000008064 anhydrides Chemical class 0.000 abstract 1
238000010504 bond cleavage reaction Methods 0.000 abstract 1
238000013375 chromatographic separation Methods 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
230000007017 scission Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT96915261T 1995-06-07 1996-05-06 Peptide und gewinnungsverfahren ATE260933T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
RU95108559A RU2107692C1 (ru)	1995-06-07	1995-06-07	Пептид и способ его получения
PCT/RU1996/000116 WO1996040740A1 (fr)	1995-06-07	1996-05-06	Peptide et procede de production

Publications (1)

Publication Number	Publication Date
ATE260933T1 true ATE260933T1 (de)	2004-03-15

Family

ID=20168146

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96915261T ATE260933T1 (de)	1995-06-07	1996-05-06	Peptide und gewinnungsverfahren

Country Status (20)

Country	Link
US (1)	US5736519A (de)
EP (1)	EP0832900B1 (de)
JP (1)	JP4082522B2 (de)
CN (1)	CN1154653C (de)
AT (1)	ATE260933T1 (de)
AU (1)	AU724781B2 (de)
BR (1)	BRPI9609235B8 (de)
CA (1)	CA2222296C (de)
CZ (1)	CZ287816B6 (de)
DE (1)	DE69631762T2 (de)
DK (1)	DK0832900T3 (de)
ES (1)	ES2217311T3 (de)
HU (1)	HU228461B1 (de)
LT (1)	LT4476B (de)
LV (1)	LV12074B (de)
PT (1)	PT832900E (de)
RU (1)	RU2107692C1 (de)
SK (1)	SK281825B6 (de)
UA (1)	UA48974C2 (de)
WO (1)	WO1996040740A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2107691C1 (ru) *	1995-03-02	1998-03-27	Дейгин Владислав Исакович	Пептид и способ его получения
US5916878A (en) *	1995-11-28	1999-06-29	Edward T. Wei	γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
US6159940A (en) *	1996-02-28	2000-12-12	Immunotech Developments Inc.	Method for modulating hemopoiesis
DE19712633A1 (de) *	1997-03-26	1998-10-08	Laves Arzneimittel	Verwendung von gamma-Aminobuttersäure als Interleukinbildungsstimulans
IL145926A0 (en)	2001-10-15	2002-07-25	Mor Research Applic Ltd	Peptide epitopes of mimotopes useful in immunomodulation
IL155136A0 (en)	2003-02-10	2003-10-31	Enzymotec Ltd	A composition for reducing blood cholesterol and triglycerides
US20060233863A1 (en)	2003-02-10	2006-10-19	Enzymotec Ltd.	Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
JP4629033B2 (ja)	2003-03-28	2011-02-09	サイクローン・ファーマシューティカルズ・インコーポレイテッド	チモシンα１によるアスペルギルス感染の治療
US20090232916A1 (en) *	2004-08-09	2009-09-17	Avidor Shulman	Food products for diabetics
AU2005270831B2 (en)	2004-08-10	2011-08-25	Enzymotec Ltd.	Mixture of phytosterol ester(s) and 1, 3-diglyceride(s) for use in the treatment of medical conditions
WO2006131833A2 (en) *	2005-03-18	2006-12-14	Centre National De La Recherche Scientifique	New hybrid oligomers. their preparation process and pharmaceutical compositions containing them
US7919468B2 (en)	2005-04-07	2011-04-05	Centre National De La Recherche Scientifique (C.N.R.S.)	Compounds useful as modulators of the proteasome activity
WO2007000768A2 (en) *	2005-06-28	2007-01-04	Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science	Gliomedin, fragments thereof and methods of using same
RU2320364C1 (ru) *	2006-08-21	2008-03-27	Закрытое Акционерное Общество "Центр "Пептос"	Способ лечения злокачественных новообразований
CA2569204A1 (en)	2006-11-28	2008-05-28	Apotex Technologies Inc.	Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan
CA2571645A1 (en)	2006-12-19	2008-06-19	Apotex Technologies Inc.	Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
MX2009008641A (es)	2007-02-13	2009-09-14	Sciclone Pharmaceuticals Inc	Composiciones para el tratamiento o prevencion del deterioro, lesion o daño a tejido debido a enfermedad de las mucosas.
CA2579119C (en)	2007-02-16	2013-03-05	Apotex Technologies Inc.	Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan
WO2008142693A2 (en) *	2007-05-22	2008-11-27	Yeda Research And Development Co. Ltd.	Regulation of myelination by nectin-like (necl) molecules
RU2410391C1 (ru) *	2009-06-03	2011-01-27	Общество с ограниченной ответственностью "Пептос Фарма"	Пептиды, влияющие на регенерацию кроветворной системы, и фармацевтическая композиция на их основе
EA201391419A1 (ru) *	2011-03-31	2014-02-28	Апотекс Текнолоджиз Инк.	Пролекарства d-изоглутамил-[d/l]-триптофана
CA2831429A1 (en) *	2011-03-31	2012-10-04	Apotex Technologies Inc.	Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma- glutamyl-l-tryptophan
CN102417474B (zh) *	2011-09-26	2014-07-02	深圳翰宇药业股份有限公司	D-异谷氨酰基-d-色氨酸制备的新方法
RU2634258C1 (ru) *	2016-11-08	2017-10-24	федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН)	Наполнитель для капсульного ингалятора

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3832337A (en) *	1970-07-28	1974-08-27	Squibb & Sons Inc	Peptide enzyme inhibitors
GB1526367A (en) *	1976-10-12	1978-09-27	Ici Ltd	Polypeptide
HU184481B (en) *	1981-10-02	1984-08-28	Richter Gedeon Vegyeszet	Process for producing tripeptides for diminishing appetite
JPS5921656A (ja) *	1982-07-28	1984-02-03	Takeda Chem Ind Ltd	ポリペプチド誘導体
CH659586A5 (de) *	1985-07-02	1987-02-13	Le G Ped I	Arzneimittel aus dem thymus und verfahren zu dessen herstellung.
CA1286989C (en) *	1985-12-26	1991-07-30	A. Arthur Gottlieb	Immunoamplifiers and related compositions
IT1216908B (it) *	1987-03-19	1990-03-14	Eniricerche Spa	Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche.
DE3873327D1 (de) *	1987-12-30	1992-09-03	Vsesojuznyj Kardiologitsches	Arzneimittelzubereitung zur behandlung des immunmangels.
US5021551A (en) *	1989-01-18	1991-06-04	Washington University	Method of enhancing peptide immunogenicity
SU1737798A1 (ru) *	1989-04-11	1995-03-20	Институт клинической иммунологии СО АМН СССР	Способ получения иммуностимулирующих тимусных полипептидов
IT1230733B (it)	1989-06-30	1991-10-29	Eniricerche Spa	Analoghi della timopentina retro invertita a tutti i legami, il metodo per la loro sintesi ed il loro impiego per la preparazione di composizioni farmaceutiche.
IT1263042B (it) *	1993-01-15	1996-07-24	Enichem Polimeri	Composizione da stampaggio a base di polifenilenetere
AU7392294A (en) *	1993-07-21	1995-02-20	Vladimir Khatskelevich Khavinson	Pharmaceutical with immunomodulating activity

1995
- 1995-06-07 RU RU95108559A patent/RU2107692C1/ru active
1996
- 1996-05-06 EP EP96915261A patent/EP0832900B1/de not_active Expired - Lifetime
- 1996-05-06 ES ES96915261T patent/ES2217311T3/es not_active Expired - Lifetime
- 1996-05-06 UA UA98010039A patent/UA48974C2/uk unknown
- 1996-05-06 HU HU9801990A patent/HU228461B1/hu not_active IP Right Cessation
- 1996-05-06 SK SK1669-97A patent/SK281825B6/sk not_active IP Right Cessation
- 1996-05-06 CA CA002222296A patent/CA2222296C/en not_active Expired - Fee Related
- 1996-05-06 CN CNB961951532A patent/CN1154653C/zh not_active Expired - Fee Related
- 1996-05-06 JP JP50033197A patent/JP4082522B2/ja not_active Expired - Fee Related
- 1996-05-06 WO PCT/RU1996/000116 patent/WO1996040740A1/ru not_active Ceased
- 1996-05-06 BR BRPI9609235A patent/BRPI9609235B8/pt not_active IP Right Cessation
- 1996-05-06 DE DE69631762T patent/DE69631762T2/de not_active Expired - Lifetime
- 1996-05-06 CZ CZ19973905A patent/CZ287816B6/cs not_active IP Right Cessation
- 1996-05-06 DK DK96915261T patent/DK0832900T3/da active
- 1996-05-06 PT PT96915261T patent/PT832900E/pt unknown
- 1996-05-06 AU AU57076/96A patent/AU724781B2/en not_active Ceased
- 1996-05-06 AT AT96915261T patent/ATE260933T1/de active
- 1996-06-07 US US08/657,888 patent/US5736519A/en not_active Expired - Lifetime
1997
- 1997-12-19 LV LVP-97-266A patent/LV12074B/lv unknown
1998
- 1998-01-07 LT LT98-004A patent/LT4476B/lt not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU724781B2 (en)	2000-09-28
LT98004A (en)	1998-10-26
CZ390597A3 (cs)	1998-08-12
CA2222296A1 (en)	1996-12-19
LV12074A (lv)	1998-06-20
HUP9801990A3 (en)	1999-06-28
LT4476B (lt)	1999-03-25
SK166997A3 (en)	1998-04-08
LV12074B (lv)	1998-08-20
JPH11513016A (ja)	1999-11-09
DE69631762D1 (de)	2004-04-08
EP0832900B1 (de)	2004-03-03
CN1189837A (zh)	1998-08-05
AU5707696A (en)	1996-12-30
CA2222296C (en)	2001-10-09
BRPI9609235B8 (pt)	2016-09-27
ES2217311T3 (es)	2004-11-01
HUP9801990A2 (hu)	1999-02-01
UA48974C2 (uk)	2002-09-16
SK281825B6 (sk)	2001-08-06
US5736519A (en)	1998-04-07
WO1996040740A1 (fr)	1996-12-19
DE69631762T2 (de)	2005-03-10
CZ287816B6 (en)	2001-02-14
DK0832900T3 (da)	2004-06-21
HK1014965A1 (en)	1999-10-08
PT832900E (pt)	2004-07-30
RU2107692C1 (ru)	1998-03-27
EP0832900A1 (de)	1998-04-01
CN1154653C (zh)	2004-06-23
BR9609235B1 (pt)	2009-01-13
JP4082522B2 (ja)	2008-04-30
HU228461B1 (en)	2013-03-28
EP0832900A4 (de)	1999-10-06
BR9609235A (pt)	1999-12-21

Legal Events

Date

Code

Title

Description

2004-11-15

UEP

Publication of translation of european patent specification

Ref document number: 0832900

Country of ref document: EP

Publication	Publication Date	Title
BR9609235B1 (pt)	2009-01-13	peptÍdeo.
Jakubke et al.	1985	Basic principles of protease‐catalyzed peptide bond formation
LV11993A (lv)	1998-03-20	Peptidi un to iegusanas panemiens
RU95108559A (ru)	1997-08-27	Пептид и способ его получения
Takagaki et al.	1983	The membrane-embedded segment of cytochrome b5 as studied by cross-linking with photoactivatable phospholipids.
Spatola et al.	1996	Rediscovering an endothelin antagonist (BQ-123): A self-deconvoluting cyclic pentapeptide library
PT779076E (pt)	2005-07-29	Peptidos, um metodo para a sua obtencao e um composto farmaceutico om base nestes
RU94024278A (ru)	1997-11-10	Пептид и способ его получения
RU2006111491A (ru)	2007-11-20	Новые противоопухолевые соединения
CA1157466A (en)	1983-11-22	Peptides having thymopoietin-like activity
US9850274B2 (en)	2017-12-26	Peptide combination
Or et al.	1991	Cysteine alkylation in unprotected peptides: synthesis of a carbavasopressin analog by intramolecular cysteine alkylation
Okamoto et al.	1976	Synthesis of a cross‐linked polypentapeptide of tropoelastin
Marks et al.	1974	Novel enzymes involved in the inactivation of hypothalamo-hypophyseal hormones
Bodanszky	1988	Design of Schemes for Peptide Synthesis
Gu et al.	2001	Synthesis of β-Turn Mimetics:[5, 5]-Fused Bicyclic γ-Lactam Dipeptide Analogues
Yonezawa et al.	1978	SOLID PHASE SYNTHESIS OF PORCINE LH‐RELEASING HORMONE WITH HYDROGEN CHLORIDE IN FORMIC ACID AS THE DEBLOCKING REAGENT
St-Pierre	1987	Functional Identification of Peptide Receptors
LILI et al.	1988	Studies on Peptides. CLXIV. Solution-Phase Synthesis of a 36-Residue Peptide Amide Corresponding to the Entire Amino Acid Sequence of Chicken Antral Peptide